This result illustrated that the gene signaling in pancreatic adenocarcinoma was mediated by the activation of K-ras through missense mutations, or by the inactivation of p53 through truncating mutation and missense mutation. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.